Published on Roswell Park Cancer Institute (http://www.roswellpark.org)

Staff Physician
Roswell Park Cancer Institute
Associate Professor GFT - Surgery
School of Medicine and Biomedical Sciences, State University of New York at Buffalo
Profile
Areas of Expertise: 
Barrett’s esophagus
Colon cancer
Esophageal cancer
Pancreatic cancer
Stomach cancer
Research
Research Interests: 
Effects of chemotherapy and radiation therapy on molecular esophageal tumor markers
Endoscopic ablation of obstructing esophageal and colon tumors with Nd-YAG laser therapy
Endoscopic ablation of obstructing esophageal and colon tumors with photodynamic therapy (PDT)
Endoscopic mucosal resection for esophagus and stomach cancer
Role of PDT in the treatment of patients with high-grade dysplasia in Barrett’s esophageal metaplasia
Treatment modalities for esophageal cancer
Background Information
Education and Training: 
MD - Facultad de Medicine, Universidad de Nuevo Leon, Monterrey, Mexico
Residency: 
Buffalo General Hospital, Buffalo, NY
Board Certification: 
Surgery, American Board of Surgery
Fellowships: 
Roswell Park Cancer Institute, Buffalo, NY
Publications
Publications: 
  • Chadha KS, Chadha KS, Schiff M , Sitrin MD , Wilding GE , Nava H. Clinical outcomes of using a conservative approach of late esophageal stent placement in palliation of malignant dysphagia. Journal of gastrointestinal cancer 2010; 41(3):173-178
  • Lee RY , Flaherty L , Khushalani NI , Kanehira K , Nwogu C , Yendamuri S , Nava HR , Yang GY. Aorto-esophageal fistula: a rare fatal case caused by esophageal malignancy. Journal of gastrointestinal oncology 2010; 1(1):64-67
  • May KS , Lamonica D , Nava HR , Gibbs JF , Yendamuri SS , Nwogu CE , Iyer RV , Yap JC , Warner JC , Russo RC , Malhotra HK , Flaherty L , Wilding GE , Chandrasekhar R , Khushalani NI , Yang GY , Thomas Jr CR. Association of Technetium(99m) MAG-3 renal scintigraphy with change in creatinine clearance following chemoradiation to the abdomen in patients with gastrointestinal malignancies. Journal of gastrointestinal oncology 2010; 1(1):7-15
  • Yendamuri S , Gutierrez L , Oni A , Mashtare T , Khushalani N, Yang G , Nava H , Demmy T , Nwogu C. Does circular stapled esophagogastric anastomotic size affect the incidence of postoperative strictures?. Journal of surgical research 2011; 165(1):1-4
  • Khushalani NI, Nava HR, Nwogu CE, Yendamuri SS, Iyer RV, Wang D, Miecznikowski J, Tan W, Yang G, Javle MM. Gene expression profile (GEP) for the prediction of pathologic complete response (pCR): Preliminary data from a neoadjuvant study of capecitabine (C), oxaliplatin (OXP), and radiation (RT) for esophageal cancer (EC). Journal of clinical oncology 2010; 28(15 Suppl.):4100
  • Bronner MP, Grace M, Pedrosa M, Marcon N, Canto MI, Barr H, Nishioka N, Sivak MV, Nava HR, Kimmey M, Lightdale CJ, Burdick JS, Wang KK, Haggitt RC, Taylor SL, Overholt BF, Depot M. Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia. Gastroenterology 2009; 136(1):56-64; quiz 351-352
  • Javle MM, Smith PF, Prey JD, Clark KR, LeVea C, Nava HR, Schiff MD, Vinjamaram S, O'Malley L, Wilding GE, Nwogu CE, Yang G, Pendyala L. Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysis. Cancer investigation 2009; 27(2):193-200
  • Singh Chadha K, Thatikonda C, Schiff M, Nava H, Sitrin MD. Outcomes of percutaneous endoscopic gastrostomy tube placement using a T-fastener gastropexy device in head and neck and esophageal cancer patients. Nutrition in clinical practice 2010; 25(6):658-662
  • Iyer R, Javle M, Robins M, Levea C, Litwin A, Nava H, Tan W, Shefter T, Yang G, Khushalani NI. Phase II multicenter study of erlotinib and radiation therapy (RT) for elderly patients (PTS) with esophageal carcinoma (EC)- final report. Annals of oncology 2010; 21(Suppl. 8):259-260
  • Javle M, Pande A, Iyer R, Yang G, LeVea C, Wilding G, Black J, Nava H, Nwogu C. Pilot study of gefitinib, oxaliplatin, and radiotherapy for esophageal adenocarcinoma: tissue effect predicts clinical response. American journal of clinical oncology 2008; 31(4):329-334
  • Agrawal S, McCarron EC, Gibbs JF, Nava HR, Wilding GE, Rajput A. Surgical management and outcome in primary adenocarcinoma of the small bowel. Annals of surgical oncology 2007; 14(8):2263-2269
  • Donthireddy KR, Ailawadhi S, Nasser E, Schiff MD, Nwogu CE, Nava HR, Javle MM. Malignant gastroparesis: pathogenesis and management of an underrecognized disorder. Journal of supportive oncology 2007; 5(8):355-363
  • Foster JM, Filocamo P, Nava H, Schiff M, Hicks W, Rigual N, Smith J, Loree T, Gibbs JF. The introducer technique is the optimal method for placing percutaneous endoscopic gastrostomy tubes in head and neck cancer patients. Surgical endoscopy 2007; 21(6):897-901
  • Gibbs JF, Rajput A, Chadha KS, Douglas WG, Hill H, Nwogu C, Nava HR, Sabel MS. The changing profile of esophageal cancer presentation and its implication for diagnosis. Journal of the National Medical Association 2007; 99(6):620-626
  • O'Connor BM, Chadha MK, Pande A, Lombardo JC, Nwogu CE, Nava HR, Yang G, Javle MM. Concurrent oxaliplatin, 5-fluorouracil, and radiotherapy in the treatment of locally advanced esophageal carcinoma. Cancer journal (Sudbury, Mass.) 2007; 13(2):119-124
  • Overholt BF, Grace M, Bronner MR, Pedrosa M, Marcon N, Barr H, Nishioka N, Sivak MV, Nava HR, Kimmey M, Lightdale CJ, Burdick JS, Wang KK, Depot M. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointestinal endoscopy 2007; 66(3):460-468
  • Nava HR, Allamaneni SS, Dougherty TJ, Cooper MT, Tan W, Wilding G, Henderson BW. Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with barrett's esophagus. Lasers in surgery and medicine 2011; 43(7):705-712
  • Malik NK, Warren GW, Yang G, Zeeck K, Papsidero T, Patil S, Khushalani NI, Sher T, Yendamuri SS, Nava HR, Salerno May K. Response-based outcomes in patients with esophageal cancer treated with primarily non-cisplatin and 5-fluorouracil-based trimodality therapy : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2011; 29(15 Suppl.):e14620
  • Salerno May K, Malik NK, Yang G, Patil S, Flaherty L, Khushalani NI, Sher T, Yendamuri SS, Nava HR, Warren GW. The effect of smoking history on response and survival outcomes patients with in esophageal cancer treated with neoadjuvant concurrent chemoradiotherapy followed by surgery : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2011; 29(15 Suppl.):e14601
  • Iyer RV, Yang G, Schefter TE, Tan W, Nava HR, Levea C, Litwin A, Robins M, Khushalani NI. Phase II multicenter study of erlotinib with radiation therapy (RT) for elderly patients (pts) with esophageal carcinoma (EC): Final report : 2011 Gastrointestinal Cancers Symposium. Journal of clinical oncology 2011; 29(4 Suppl.):135
  • Chadha K, Thatikonda C, Miller A, Nava H, Sitrin M, Hicks W, Rigual N, Loree T, Schiff M. Outcomes of Percutaneous Endoscopic Gastrostomy Tube Placement using the Brown-Muller T-fastener Technique in Head, Neck and Esophageal Cancer patients. American journal of gastroenterology 2009; 104(Suppl. 3):Abstract #1351
  • Khushalani NI, Miecznikowski J, Wang D, Nowak N, Nava H, Nava ME, Tan W, Iyer R, Yang G, Pendyala L. Capecitabine (C), oxaliplatin (OXP), and radiation (RT) in resectable esophagus cancer (EC): A phase II trial with gene expression profiling (GEP). Journal of clinical oncology 2009; 27(15 Suppl.):Abstract #e15543
  • Pahk A, McCarthy P, Smiley S, Nava H, Yang G, Smith J, Trump D, Battiwalla M, Andrews C, Schiff M. Wireless Capsule Endoscopy as a Diagnostic Tool and Predictor of Acute and Chronic Graft-Versus-Host Disease. American journal of gastroenterology 2009; 104(Suppl. 3):Abstract #1354
  • Sharma R, Yang GY, Nava HR, Demmy TL, Nwogu CE, Yendamuri SS, Lamonica D, Tan W, Iyer RV, Khushalani NI. A single institution experience with neoadjuvant chemoradiation (CRT) with irinotecan (I) and cisplatin (C) in locally advanced esophageal carcinoma (LAEC). Journal of clinical oncology 2009; 27(15 Suppl.):Abstract #e15619
  • Malik NK, Patil S, Groman A, Nava H, Yendamuri S, Nurkin S, Sher T, Warren G, Yang G, May K. Outcomes in Patients 65 Years or Older Treated with Trimodality Therapy for Esophageal Carcinoma. International journal of radiation oncology, biology, physics 2011; 81(2 Suppl.):S312
  • Nurkin S, Nava HR, Yendamuri S, Levea CM, Nwogu C, Wilding G, Khushalani N. Outcomes of Endoscopic Resection for High Grade Dysplasia and Esophageal Cancer. Gastrointestinal endoscopy 2012; 75(4 Suppl.):473
  • Platz TA, Nurkin SJ, Fong MK, Malhotra U, Yendamuri SS, Nava HR, Warren GWr, Salerno MK. Neoadjuvant carboplatin/paclitaxel with concurrent radiotherapy followed by surgery for esophageal/gastroesophageal junction adenocarcinoma: A single-institution experience. Journal of clinical oncology 2012; 30(15 Suppl.):Abstract #e14712
Referral
Email: 
Hector.Nava@RoswellPark.org
Fax: 
716-845-1278
Source URL (retrieved on 05/22/2013 - 12:41am): http://www.roswellpark.org/hector-nava